Vjara Popova, Seraphina Kissling, Raphael Micheroli et al.: Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry Arthritis Research & Therapy, March 2023

Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis et al.: One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment The Journal of Rheumatology, March 2023

Fabienne Fröhlich, Raphael Micheroli, Monika Hebeisen et al.: HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry Clinical Rheumatology, December 2022

Catherine E. Raptis, Christoph T. Berger, Adrian Ciurea, et al.: Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases Frontiers in Immunology, October 2022

Enriqueta Vallejo-Yagüe, Theresa Burkard, et al.: Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort BMJ Open, September 2022

Kim Lauper, Delphine Sophie Courvoisier, Axel Finckh, et al.: Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration ARD, June 2022

Andrea Amstad, Diego Kyburz, et al.: Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy Rheumatology, May 2022

Michael Nissen, Bénédicte Delcoigne, Ulf Lindström, et al.: The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. Rheumatology (Oxford), March 2022

Raphael Micheroli, Adrian Ciurea, Kristina Bürki, et al.: Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort J Ultrason, February 2022

Theresa Burkhard, Andrea M. Burden, Enriqueta Vallejo-Yagüe, et al: Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland BMJ Open, January 2022

Adrian Ciurea, Raphael Micheroli, Xenofon Baraliakos, et al: Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort RMD Open, January 2022

Cathy Mireille Melong, Kim Lauper, Benoit Gilbert et al: Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab
Rheumatic & Musculoskeletal Diseases, December 2021

Christian A. Lechtenböhmer, Thomas Hügle et al: Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis Arthritis Research & Therapy, October 2021

Catherine Raptis, Diego Andrey, Christoph Berger et al.:
Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases
ACR, October 2021
Poster, October 2021
Laien Zusammenfassung

Enriqueta Vallejo-Yagüe, Andrea M. Burden, Theresa Burkard et al.: Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland MDPI, July 2021
Lay Summary

Michael J. Nissen , Burkhard Möller, Adrian Ciurea, et al.: Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors Arthritis Research & Therapy, June 2021

Ulf Lindström, Michael Nissen et al.: Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration Annals of the Rheumatic Diseases, June 2021

Diego Kyburz, Ulrich A Walker, Adrian Ciurea et al.: Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors RMD Open, April 2021

Yomei Shaw, Axel Finckh, Ulrich A Walker, Adrian Ciurea et al.: Impact of assessing patient- reported outcomes with mobile apps on patient– provider interaction Rheumatology (Oxford), March 2021

Michael J Nissen, Matthias Jarlborg, Axel Finckh et al.: Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis Rheumatology (Oxford), January 2021